Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine


Basal cell carcinoma, medulloblastoma, rhabdomyosarcoma and other human tumours are associated with mutations that activate the proto-oncogene Smoothened (SMO) or that inactivate the tumour suppressor Patched (PTCH). Smoothened and Patched mediate the cellular response to the Hedgehog (Hh) secreted protein signal, and oncogenic mutations affecting these proteins cause excess activity of the Hh response pathway1,2. Here we show that the plant-derived teratogen cyclopamine, which inhibits the Hh response3,4, is a potential ‘mechanism-based’ therapeutic agent for treatment of these tumours. We show that cyclopamine or synthetic derivatives with improved potency block activation of the Hh response pathway and abnormal cell growth associated with both types of oncogenic mutation. Our results also indicate that cyclopamine may act by influencing the balance between active and inactive forms of Smoothened.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: NIH-3T3 fibroblasts respond to ShhNp and are sensitive to cyclopamine.
Figure 2: Cyclopamine acts downstream of Ptch by inhibiting Smo activity.
Figure 3: Reversal of pathway activation and abnormal cell growth caused by oncogenic mutations in Ptch and Smo.
Figure 4: Mechanism of cyclopamine reversal of oncogenic Hh pathway activation.

Similar content being viewed by others


  1. Goodrich, L. V. & Scott, M. P. Hedgehog and patched in neural development and disease. Neuron 21 , 1243–1257 (1998).

    Article  CAS  Google Scholar 

  2. Ingham, P. W. Transducing hedgehog: the story so far. EMBO J. 17, 3505–3511 (1998).

    Article  CAS  Google Scholar 

  3. Cooper, M. K., Porter, J. A., Young, K. E. & Beachy, P. A. Plant-derived and synthetic teratogens inhibit the ability of target tissues to respond to Sonic hedgehog signaling. Science 280 , 1603–1607 (1998).

    Article  ADS  CAS  Google Scholar 

  4. Incardona, J. P., Gaffield, W., Kapur, R. P. & Roelink, H. The teratogenic Veratrum alkaloid cyclopamine inhibits sonic hedgehog signal transduction. Development 125, 3553 –3562 (1998).

    CAS  Google Scholar 

  5. Chiang, C. et al. Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function. Nature 383, 407–413 (1996).

    Article  ADS  CAS  Google Scholar 

  6. Hahn, H., Wojnowski, L., Miller, G. & Zimmer, A. The patched signaling pathway in tumorigenesis and development: lessons from animal models. J. Mol. Med. 77, 459– 468 (1999).

    Article  CAS  Google Scholar 

  7. Hahn, H. et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85, 841–851 (1996).

    Article  CAS  Google Scholar 

  8. Johnson, R. L. et al. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 272, 1668–1671 (1996).

    Article  ADS  CAS  Google Scholar 

  9. Gailani, M. et al. The role of the human homologue of Drosophila patched in sporadic basal cell carcinomas. Nature Genet. 14 , 78–81 (1996).

    Article  CAS  Google Scholar 

  10. Pietsch, T. et al. Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched. Cancer Res. 57, 2085–2088 ( 1997).

    CAS  PubMed  Google Scholar 

  11. Reifenberger, J. et al. Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res. 58, 1798–1803 (1998).

    CAS  PubMed  Google Scholar 

  12. Raffel, C. et al. Sporadic medulloblastomas contain PTCH mutations. Cancer Res. 57, 842–845 (1997).

    CAS  Google Scholar 

  13. Xie, J. et al. Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature 391, 90–92 (1998).

    Article  ADS  CAS  Google Scholar 

  14. Gibbs, J. B. Mechanism-based target identification and drug discovery in cancer research. Science 287, 1969–1973 (2000).

    Article  ADS  CAS  Google Scholar 

  15. Keeler, R. F. & Binns, W. Teratogenic compounds of Veratrum californicum (Durand). V. Comparison of cyclopian effects of steroidal alkaloids from the plant and structurally related compounds from other sources. Teratology 1, 5–10 ( 1968).

    Article  CAS  Google Scholar 

  16. Aza-Blanc, P., Remírez-Weber, F.-A., Laget, M.-P., Schwartz, C. & Kornberg, T. B. Proteolysis that is inhibited by Hedgehog targets cubitus interruptus protein to the nucleus and converts it to a repressor. Cell 89, 1043– 1053 (1997).

    Article  CAS  Google Scholar 

  17. Methot, N. & Basler, K. Hedgehog controls limb development by regulating the activities of distinct transcriptional activator and repressor forms of Cubitus interruptus. Cell 96, 819 –831 (1999).

    Article  CAS  Google Scholar 

  18. Chen, C. H. et al. Nuclear trafficking of Cubitus interruptus in the transcriptional regulation of Hedgehog target gene expression. Cell 98, 305–316 (1999).

    Article  CAS  Google Scholar 

  19. Wang, B., Fallon, J. & Beachy, P. Hedgehog-regulated processing of Gli3 produces an anterior/posterior repressor gradient in the developing vertebrate limb. Cell 100, 423–434 (2000).

    Article  CAS  Google Scholar 

  20. Pepinsky, R. B. et al. Identification of a palmitic acid-modified form of human Sonic hedgehog. J. Biol. Chem. 273, 14037– 14045 (1998).

    Article  CAS  Google Scholar 

  21. Sasaki, H., Hui, C.-C., Nakafuku, M. & Kondoh, H. A binding site for Gli proteins is essential for HNF3β floor plate enhancer activity in transgenics and can respond to Shh in vitro. Development 124, 1313–1322 ( 1997).

    CAS  PubMed  Google Scholar 

  22. Beachy, P. A. et al. Multiple roles of cholesterol in hedgehog protein biogenesis and signaling. Cold Spring Harb. Symp. Quant. Biol. 62, 191–204 (1997).

    Article  CAS  Google Scholar 

  23. Lange, Y., Ye, J., Rigney, M. & Steck, T. L. Regulation of endoplasmic reticulum cholesterol by plasma membrane cholesterol. J. Lipid. Res. 40, 2264–2270 (1999).

    CAS  PubMed  Google Scholar 

  24. Goodrich, L. V., Milenkovic, L., Higgins, K. M. & Scott, M. P. Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 277, 1109–1113 ( 1997).

    Article  CAS  Google Scholar 

  25. Murone, M., Rosenthal, A. & de Sauvage, F. J. Sonic hedgehog signaling by the patched-smoothened receptor complex. Curr. Biol. 9, 76– 84 (1999).

    Article  CAS  Google Scholar 

  26. Fuse, N. et al. Sonic hedgehog protein signals not as a hydrolytic enzyme but as an apparent ligand for patched. Proc. Natl Acad. Sci. USA 96, 10992–10999 (1999).

    Article  ADS  CAS  Google Scholar 

  27. Shin, S. I., Freedman, V. H., Risser, R. & Pollack, R. Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro. Proc. Natl Acad. Sci. USA 72, 4435–4439 ( 1975).

    Article  ADS  CAS  Google Scholar 

  28. Bond, R. A. et al. Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the beta 2-adrenoceptor. Nature 374, 272–276 ( 1995).

    Article  ADS  CAS  Google Scholar 

  29. Bourne, H. R. How receptors talk to trimeric G proteins. Curr. Opin. Cell Biol. 9, 134–142 ( 1997).

    Article  CAS  Google Scholar 

Download references


We thank P. A. Cole, D. Leahy, J. Nathans, R. Reed and G. Seydoux for critical review of the manuscript, W. Gaffield for Veratrum extracts and K. Young for technical assistance. J.T. was supported by the Finnish Academy and the European Molecular Biology Organization. J.K.C. is a recipient of a postdoctoral fellowship from the Damon Runyon-Walter Winchell Cancer Research Fund and M.K.C. was supported by a postdoctoral fellowship from the Howard Hughes Medical Institute and a career development award from the Burroughs Wellcome Fund. P.A.B. and M.P.S. are investigators of the Howard Hughes Medical Institute.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Philip A. Beachy.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Taipale, J., Chen, J., Cooper, M. et al. Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine. Nature 406, 1005–1009 (2000).

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI:

This article is cited by


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing